Literature DB >> 2549845

The pedunculopontine nucleus in Parkinson's disease.

R M Zweig1, W R Jankel, J C Hedreen, R Mayeux, D L Price.   

Abstract

This study demonstrated a significant loss of neurons within the lateral part of the pedunculopontine nucleus pars compacta in individuals with idiopathic Parkinson's disease and in individuals with combined Parkinson's and Alzheimer's disease. We also examined the extent of neuronal loss within the substantia nigra pars compacta, locus ceruleus, dorsal raphe nucleus, and nucleus basalis of Meynert. The number of pedunculopontine nucleus pars compacta neurons in the patients with Parkinson's or Parkinson's and Alzheimer's disease was reduced (average, 40%) in comparison with the number in control subjects or patients with Alzheimer's disease (p less than 0.01). This finding correlated significantly with the extent of loss of substantia nigra pars compacta neurons (p less than 0.01).

Entities:  

Mesh:

Year:  1989        PMID: 2549845     DOI: 10.1002/ana.410260106

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  76 in total

Review 1.  An update expert opinion on management and research strategies in Parkinson's disease psychosis.

Authors:  Jennifer G Goldman; Christina L Vaughan; Christopher G Goetz
Journal:  Expert Opin Pharmacother       Date:  2011-06-02       Impact factor: 3.889

2.  Cholinergic and non-cholinergic mesopontine tegmental neurons projecting to the subthalamic nucleus in the rat.

Authors:  Takako Kita; Hitoshi Kita
Journal:  Eur J Neurosci       Date:  2010-12-31       Impact factor: 3.386

Review 3.  Role of the pedunculopontine nucleus in controlling gait and sleep in normal and parkinsonian monkeys.

Authors:  C Karachi; Chantal Francois
Journal:  J Neural Transm (Vienna)       Date:  2017-01-13       Impact factor: 3.575

Review 4.  Restoration of locomotive function in Parkinson's disease by spinal cord stimulation: mechanistic approach.

Authors:  Romulo Fuentes; Per Petersson; Miguel A L Nicolelis
Journal:  Eur J Neurosci       Date:  2010-10       Impact factor: 3.386

Review 5.  The pedunculopontine tegmental nucleus and experimental parkinsonism. A review.

Authors:  Masaru Matsumura
Journal:  J Neurol       Date:  2005-10       Impact factor: 4.849

6.  Descending brainstem projections of the pedunculopontine tegmental nucleus in the rat.

Authors:  I Grofova; S Keane
Journal:  Anat Embryol (Berl)       Date:  1991

Review 7.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

8.  The integrative role of the pedunculopontine nucleus in human gait.

Authors:  Brian Lau; Marie-Laure Welter; Hayat Belaid; Sara Fernandez Vidal; Eric Bardinet; David Grabli; Carine Karachi
Journal:  Brain       Date:  2015-03-12       Impact factor: 13.501

Review 9.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

10.  Contemporaneous bilateral postero-ventral pallidotomy for early onset "juvenile type" Parkinson's disease. Case report.

Authors:  R P Iacono; R R Lonser; S Yamada
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.